Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps will ...
DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom (NASDAQ: DXCM), a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new ...
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...
The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...
DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...
SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today that its Development and Commercialization Agreement with Dexcom, Inc., has been expanded to include ...
New products in development with partners Johnson & Johnson and Tandem could help Dexcom outmaneuver its chief competitor, Medtronic. More than 365 million people have diabetes worldwide and estimates ...
As med tech outfits race to develop innovative, noninvasive technology for diabetes monitoring, Dexcom ($DXCM) snagged FDA approval for a new artificial pancreas ...
SAN DIEGO SAN DIEGO — Shares of DexCom jumped 21 percent Thursday after the San Diego medical device maker reported surging revenue and a lower net loss for the second quarter ended June 30. DexCom ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback